Impact of adult growth hormone deficiency on daily functioning and well-being

被引:20
作者
Brod M. [1 ]
Pohlman B. [1 ]
Højbjerre L. [2 ]
Adalsteinsson J.E. [2 ]
Rasmussen M.H. [2 ]
机构
[1] Brod Group, 219 Julia Avenue, Mill Valley, 94941, CA
[2] Novo Nordisk A/S, Global Development, Vandtarnsvej 114, Søborg
关键词
Adults; Daily functioning; Growth hormone deficiency; Patient-reported outcome measure; Well-being;
D O I
10.1186/1756-0500-7-813
中图分类号
学科分类号
摘要
Background: Adult Growth Hormone Deficiency (AGHD) is a debilitating condition resulting from tumors, pituitary surgery, radiation of the head, head injury, or hypothalamic-pituitary disease. This qualitative study was conducted to better understand the multi-faceted impacts and treatment effects of GHD on adult patients' daily lives. Seven focus groups and four telephone interviews were conducted in three countries. Eligible AGHD patients were age 22 or older who had started and stopped growth hormone treatment at least once as an adult. Transcripts were analyzed thematically. Results: Thirty-nine patients were interviewed; majority etiology was pituitary disease or tumor (62%). Thirty-four patients (87%) were currently on growth hormone replacement therapy; therapy initiation mean age was 43 years. Analysis identified five domains of disease impact: 1) Psychological Health-changed body or self-image and negative emotional impacts; 2) Physical Health-problems with sleep/fatigue, sex drive, weight gain, hair, skin, muscle/bone loss; 3) Cognition-concentration or memory trouble; 4) Energy Loss and its negative impacts (productivity, exercise, chores, socialization, or motivation); and 5) Treatment Effect-treatment enhances quality of life, enabling patients to increase effort (exercise, chores, or work improvements). Energy and sleep are improved. Saturation of themes was reached after the sixth focus group. A conceptual model of GHD disease impacts was developed. Conclusions: Untreated AGHD has significant negative impacts for patients, which treatment often improves. It is important for clinicians and researchers to understand these multiple impacts so that they can address them in individualized treatment plans and incorporate them when assessing treatment outcomes. © 2014 Brod et al.
引用
收藏
相关论文
共 18 条
[1]  
Molitch M.E., Clemmons D.R., Malozowski S., Merriam G.R., Vance M.L., Society E., Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 96, pp. 1587-1609, (2011)
[2]  
Kaufman J.M., Taelman P., Vemeulen A., Vandeweghe M., Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiences of childhood onset, J Clin Endocrinol Metab, 74, pp. 118-123, (1992)
[3]  
Stochholm K., Christiansen J.S., The Epidemiology of Growth Hormone Deficiency, pp. 153-168, (2011)
[4]  
Chrisouldou A., Kousta E., Beshyah S.A., Robinson S., Johnston D.G., How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults, Baillieres Clin Endocrinol Metab, 12, pp. 261-279, (1998)
[5]  
McGauley G.A., Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency, Acta Paediatr Scand Suppl, 356, pp. 70-72, (1989)
[6]  
Rosen T., Wiren L., Wilhelmsen L., Wiklund I., Bengtsson B.A., Decreased psychological well-being in adult patients with growth hormone deficiency, Clin Endocrinol (Oxf), 40, pp. 111-116, (1994)
[7]  
Mahajan T., Crown A., Checkley S., Farmer A., Lightman S., Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life, Eur J Endocrinol, 151, pp. 325-332, (2004)
[8]  
Malik I.A., Foy P., Wallymahmed M., Wilding J.P., MacFarlane I.A., Assessment of quality of life in adults receiving long-Term growth hormone replacement compared to control subjects, Clin Endocrinol (Oxf), 59, pp. 75-81, (2003)
[9]  
Stouthart P.J., Deijen J.B., Roffel M., HA D-v d W: Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy, Psychoneuroendocrinology, 28, pp. 612-626, (2003)
[10]  
McMillan C.V., Bradley C., Gibney J., Healy M.L., Russell-Jones D.L., Sonksen P.H., Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency, Clin Endocrinol (Oxf, 59, pp. 467-475, (2003)